Essentials of diabetic care - PowerPoint PPT Presentation

1 / 46
About This Presentation
Title:

Essentials of diabetic care

Description:

Essentials of diabetic care By Prof. Fathi El-Gamal Aminoacid derivative D-phenyl alanine ; eg. Nateglinide Drug combinations Any groups of drugs listed above can be ... – PowerPoint PPT presentation

Number of Views:262
Avg rating:3.0/5.0
Slides: 47
Provided by: ext5
Category:

less

Transcript and Presenter's Notes

Title: Essentials of diabetic care


1
Essentials of diabetic care
  • By
  • Prof. Fathi El-Gamal

2
Diabetic care
  • Aims of diabetic care
  • Alleviation of symptoms
  • quality of life enhancement
  • education of the patient and their family
  • minimisation of complications
  • reduction of early mortality.

3
Presentation
  • Asymptomatic
  • may be detected on routine screening during well
    man!
  • woman checks or
  • opportunistic urine screening for glucose.
  • A national screening programme is considered.
  • Sub-acute
  • weight ?,
  • polydipsia, polyuria,
  • lethargy, irritability,
  • infections (candidiasis, skin infection,
    recurrent infections slow to clear),
  • genital itching,
  • blurred vision,
  • tingling in hands/feet.

4
Presentation
  • Acute
  • ketoacidosis.
  • Complications
  • neuropathy,
  • nephropathy,
  • arterial or eye disease.

5
Diagnosis
  • If an abnormality is foundrepeat.
  • Diagnosis is made after 2 abnormal venous blood
    glucose readings sent to a laboratory
  • fasting sugar 7.0 mmol / l (126 mg) or
  • sugar 2h. after 75g of glucose (350 ml of
    Lucozade) 1l.l mmol / l (200 mg)

6
Definitions
  • Impaired fasting glycaemia
  • Fasting glucose 6.1 and lt7mmol/l. ( 110
    lt126mg).
  • Check glucose tolerance test.
  • Impaired glucose tolerance
  • Fasting sugar lt7.0mmol/l (126mg) and 2h.
    Glucose tolerance test sugar is 7.011.l mmol / l
    (126mg - 200mg).
  • Impaired glucose tolerance and impaired fasting
    glucose are both risk factors for DM.
  • Follow-up with annual fasting blood sugar.
  • 4 / year. develop DM.
  • Treat cardiovascular risk factors aggressively.

7
Caution
  • Blood glucose may be temporarily elevated during
  • acute illness,
  • after trauma or surgery or
  • during short courses of blood glucose raising
    drugs
  • If HbA1c gt 7 DM is likely.

8
Diabetes care Organization of care
  • GP diabetic clinics can be as effective as
    hospital clinics in achieving diabetic control.

9
Features of well-organized care
  • Use of a register and structured records (often
    available as part of in-house computer software)
  • regular review, with follow up of defaulters,
    following a protocol for care
  • thorough annual review (see below) with recall
    system
  • provision of protected time for the clinic

10
Features of well-organized care
  • availability of good quality written G
    information for patients
  • open access for patients to receive advice
  • multidisciplinary team covering all aspects of
    diabetes careGPs, diabetes nurse
    specialists/assistants and educators
  • access to dieticians and podiatrists
  • quality monitoring through audit and patient
    feedback
  • continuing education for professional staff.

11
Routine diabetic review
  • Ideally occurs every 6 months , or according to
    need.
  • Should include
  • 1. Problems review
  • recent life-events
  • new symptoms
  • difficulties with management since last visit.

12
Routine diabetic review
  • 2. Review of -
  • self-monitored results (and discussion of their
    meaning)
  • dietary behaviours
  • physical activity
  • smoking
  • diabetes education,
  • skills and foot care
  • blood glucose,
  • Lipid and BP therapy and results
  • other medical conditions and therapy affecting DM.

13
Routine diabetic review
  • 3. Management of
  • arterial/foot risk factors complications.
  • 4. Analysis and planning
  • agreement on the main points covered, targets for
    coming months, changes in therapy, interval to
    next consultation.
  • 5. Recording
  • completion of structured record patient-held
    record.

14
Annual Review
  • As for routine review plus
  • 1. Review of any symptoms of IHD, peripheral
    vascular disease,
  • neuropathy or erectile dysfunction.
  • 2. Review of foot problems footwear,
    deformity/joint rigidity,
  • poor skin condition, ischaemia,
    ulceration, absent pulses,
  • sensory impairment.
  • 3. Eyes visual acuity and retinal review.
  • 4. Kidney damage albumin creatinine ratio or
    dipstick for
  • microalbuminuria.

15
Annual Review
  • 5.Arterial risk blood glucose, BP, blood lipids
    and smoking.
  • 6.Review of services the patient is
    receivinghospital diabetic clinic, cardiology,
    podiatry, etc.
  • Note
  • 710 of patients in long-term residential care
    have DM.
  • The care of this group is suboptimal.
  • Agree a diabetes care plan for each affected
    resident and ensure at least annual diabetic
    review.

16
Diabetes care Education
  • Topics to cover
  • General knowledge, Knowledge of DM,
  • its progressive nature, complications and aims of
    management
  • structure of diabetic services and ways to access
    them
  • free prescriptions for patients requiring drugs
    or insulin to control their diabetes problems of
    pregnancy (for young women).

17
Diabetes care Education
  • Diet
  • Patients do not need a separate diet from the
    rest of the family or expensive diabetes food
    products.
  • A diabetic diet is a healthy diet. 50 of calorie
    intake should be from fibre-rich carbohydrate,
    with a minimum of fat (especially saturated fat),
    refined carbohydrate and alcohol.
  • Adjust total calorie intake according to desired
    BMI.
  • Recommend at least 5 portions of fresh fruit or
    vegetables/d.
  • Spread food intake evenly across the day for
    patients controlled with tablets or diet.
  • Ready made meals, processed foods, alcohol are
    often sources of hidden sugar.

18
Diabetes care Education
  • Immunizations
  • Offer influenza vaccine to all diabetics
  • and pneumococcal vaccine if gt55y. old.
  • Psychological problems
  • Education about concerns underlying the diagnosis
    of DM or development of complications.
  • Counselling as needed.

19
Diabetes care Education
  • Exercise
  • Review activity at work and in getting to and
    from the workplace,
  • hobbies and physical activity in the home
  • advise physical activity can ? insulin
    sensitivity, ? BP and improve blood lipid
    control
  • if appropriate suggest regular physical activity
    tailored to individual ability (e.g. brisk
    walking for 30min. / day exercise prescription).
  • Smoking
  • Advice on smoking cessation.

20
Diabetes care Education
  • Employment
  • Advise those on insulin that certain jobs are no
    longer possible
  • working on scaffolding or with dangerous
    machinery,
  • joining the Police or the Armed Services
  • or driving a heavy goods or public service
    vehicle.
  • Jobs without these hazards should pose no
    problems though the patient might wish to tell
    his/her employer.
  • Special advice may be needed for shift work.

21
Diabetes care Education
  • Travel
  • Management of change in time zones, transport of
    insulin and monitoring and injection equipment in
    hand-luggage
  • differences in insulin types and concentrations
    between countries
  • travel related illness (especially
    gastroenteritis)
  • need for immunisation and travel insurance.

22
Diabetes care Indices of control
  • All patients can achieve good levels of control.
  • Poorer control is acceptable in the elderly or
    others with limited life expectancy as long as
    they are symptom free.
  • Blood monitoring Essential for all patients using
    insulin and desirable for many on oral
    medication.
  • Explain the range of suitable monitoring devices
    available and train in the use of the selected
    method.
  • Frequency of self-monitoring varies according to
    need.

23
Diabetes care Indices of control
  • Set targets for pre-prandial glucose levels.
  • Assess skills (and meters if used) yearly or if
    problems with self-monitoring.
  • Evaluate reliability of results by comparison
    with HbAlc results and results obtained at
    review.
  • Glycosylated haemoglobins (HBA1c)
  • Measure at least 2 times / y ear.
  • Represent an average of blood sugar control over
    the previous
  • 6 8 weeks . (Fructosamine previous 24
    weeks).

24
Indices of control
  • Measure
    Target
  • ____________________________________________
  • Fasting blood glucose
    (110mg)
  • __________________________________________________
    ________
  • Urine
    -ve
  • __________________________________________________
    ________
  • HbAlc (normal 4.06.0)
    lt7.0
  • __________________________________________________
    ________
  • Serum cholesterol lt200
  • __________________________________________________
    ________
  • BMI (kg/m2)
    2530
  • __________________________________________________
    ________
  • B P
    130/80

25
Diabetes care
  • Treatment of
  • Type 2 diabetes

26
Healthy eating and exercise
  • Diet is the cornerstone of diabetic treatment.
  • In type 2 DM it should always be tried alone
    before medication is considered.
  • An adequate trial is normally considered to be 3
    months.
  • Increasing physical activity is also beneficial
  • (? weight, ? lipids and ? insulin sensitivity)
    though not always possible.

27
Oral hypoglycaemic agents
  • Sulphonylureas
  • Safe and effective.
  • 1st line oral treatment for non-obese patients.
  • Augment insulin secretioneffective only if there
    is some residual endogenous insulin production.
  • All are equally effective.
  • They should be taken before meals warn patients
    about possible hypoglycaemia if meals are
    omitted.

28
Oral hypoglycaemic agents
  • Start at the minimum dose and ? until either
    blood sugar is controlled or the maximum dose is
    reached.
  • Wait l mo. between dose adjustments.
  • Main side effect is weight gain.
  • If one sulphonylurea does not workanother is not
    likely to either.

29
Oral hypoglycaemic agents
  • Metformin
  • Biguanide
  • 1st line oral treatment for obese patients
    (BMIgt25).
  • Acts by ? gluconeogenesis and ? peripheral
    utilization of glucose.
  • Only effective if some endogenous insulin
    production.

30
Oral hypoglycaemic agents
  • Avoid in very elderly patients, those with
    serious heart disease, liver or renal failure or
    high alcohol intake as they have ? risk of lactic
    acidosis.
  • Hypoglycaemia is not a problem.
  • Start with the minimum dose and ? monthly until
    control is achieved or maximum dose reached.

31
Oral hypoglycaemic agents
  • Repaglinide
  • Very short acting insulin secretagogues.
  • They have rapid onset of action and half-life of
    less than an hour.
  • Improves post-prandial glucose profiles only.
  • Taken immediately before meals and omitted if the
    patient does not eat.
  • In theory causes less hypoglycaemia though yet to
    be proven.
  • Particularly useful in patients whose FGL are
    well controlled but have high PPV OR eat few or
    irregular meals
  • Generally used in combination with metformin.

32
Oral hypoglycaemic agents
  • Acarbose (alpha-glucosidase inhibitor)
  • ? carbohydrate absorption from the gut decreasing
    post-prandial hyperglycaemia.
  • Unacceptable to many patients (causes severe
    flatulence).

33
Oral hypoglycaemic agents
  • Thiazolidinediones (e.g. pioglitazone)
  • Cause ? insulin secretion, ? insulin
    sensitivity and have beneficial effect on blood
    lipid profile.
  • Guidance suggests use in combination preferably
    with metformin but if that is not possible, a
    sulphonyurea only if metformin and/or
    sulphonylurea treatment alone and combination
    therapy with metformin and a sulphonylurea have
    been ineffective or impossible to use due to
    contraindications or side effects.
  • Do not use in combination with insulin.
  • Check liver function tests before starting
    treatment and every 2mo. in the 1st year of
    treatment then 6l2mo. thereafter.

34
  • Aminoacid derivative
  • D-phenyl alanine eg. Nateglinide

35
Oral hypoglycaemic agents
  • Drug combinations
  • Any groups of drugs listed above can be used in
    combination.
  • Insulin, sulfonylurea, and meglitinides all
    increase insulin levels. They can be used
    together, but are more efficiently used with
    metformin, a TZD, or an a glucosidase
    inhibitors
  • Most (except rosiglitazone) can also be used in
    combination with insulin if diet, exercise, and
    mono-therapy are ineffective.

36
Indications for referral to specialist diabetic
services to start insulin
  • Continuing weight loss and/or persistent
    symptoms
  • Non-obese patients who are on -maximum oral
    therapy but still have poor diabetic control
  • Obese patients on maximal oral therapy but with
    poor control may benefit from insulin though
    insulin causes weight gain. A concerted effort to
    lose weight is preferable but not always
    achievable
  • Patients planning pregnancy.

37
Diabetes care Insulin
  • First line treatment for type 1 DM
  • and used when diet oral therapy have failed for
    type 2 DM.
  • Starting a patient on insulin is usually done by
    a specialist clinic with ongoing care.
  • Calculated dose of insulin is 0.5 -1.0 u /Kg/day

38
Diabetes care Insulin
  • Monitoring
  • Ask patients to keep a written diary of blood
    sugar values and time and date they are taken.
  • Advise patients to measure their blood sugar
    pre-prandially
  • 1 x /d. at different times of the daymore
    often if using multiple injection regimes, after
    dose changes or during inter-current illness.
  • Record episodes of hypoglycaemia.
  • Target Blood glucose 47mmol/l (80 126mg)
    pre-meals with hypoglycaemic episodes kept to a
    minimum.

39
Diabetes care Insulin
  • Administration
  • Deep sc injection into upper arm, thigh, buttock
    or abdomen.
  • Fat hypertrophy and scarring are minimized by
    rotation of injection sites.
  • Pen devices and conventional syringe and needle
    are equally effective.
  • In all cases prime the needle using an air shot
    (an empty needle ? insulin dose by 2u).
  • Rock pens containing pre-mixed insulins to mix
    contents before use.

40
Diabetes care Insulin
  • Common injection regimes
  • Intermediate short-acting insulin od (type 2
    only)
  • Short intermediate-acting insulin bd (main and
    pre-evening meal)
  • Short intermediate-acting insulin, short-acting
    insulin before evening meal and
    intermediate-acting insulin before bed
  • Short-acting insulin tds pre-meals and
    intermediate-acting insulin before bed
  • Combinations of oral therapy and od or bd long or
    intermediate-acting insulin.

41
Diabetes care Insulin
  • Exercise
  • ? insulin dose acting at the time of exercise or
    take 12 glucose tablets before exercise then
    check blood glucose afterwards.
  • Adjust alterations/glucose dose with experience
    of effects of exercise.
  • ? absorption of insulin from a limb site occurs
    if the limb is used in strenuous exercise
    following injection.

42
Diabetes care Insulin
  • Inter-current illness
  • Continue insulin in usual dose.
  • Keep a regular check (qds) of blood sugar.
  • If gt l3mmol/l (gt 230mg) ? insulin by 2u/d. until
    control is achieved or use top up injections of
    short-acting insulin qds prn.
  • Maintain glucose intake even if not eating (with
    Lucozade, milk or similar).
  • Admit to hospital if condition warrants
    admission unable to take glucose persistent
    vomiting, dehydration ketotic (check urine if
    blood sugar gtl3mmol/l).

43
Diabetes care Insulin
  • Poor control
  • Exclude inter-current illness.
  • Consider diet.
  • Check insulin is being used as directed and
    injection sites are not scarred or hypertrophic.
  • Consider changing insulin dose
  • ask the patient to record a glucose profile
    (blood sugar pre-meals and before bed)
  • if using gt1 insulin adjust 1 at a time
  • alter by l0 each time
  • allow 48h. between dose adjustments
  • alter dose of insulin acting at the time the
    blood sugar is most out of control
  • if blood sugar is too high, ? insulin dose and
    vice versa.

44
Hypoglycaemia
  • Emergency management
  • Advice for patients
  • Check blood sugar before driving and every 2h.
    during a long journey
  • carry glucose everywhere and sandwiches on long
    journeys
  • if hypoglycaemia occurs stop hazardous activities
    and take evasive action
  • wait until fully recovered before resuming.

45
Hypoglycaemia
  • In case of severe hypoglycaemia
  • Supply a responsible member of the family with
    glucose gel (e.g. Hypostop) and glucagon
    injectionteach him/her to use it.
  • Response is short-livedgive oral glucose (e.g.
    lucozade, glucose tablets, milk) as soon as the
    patient is conscious.
  • Recurrent hypoglycaemia
  • If occurs in a regular pattern check pattern of
    meals and activity and alter insulin to match
    needs
  • if erratic consider erratic lifestyle, alcohol,
    problems with absorption, errors in
    administration, gastroparesis
  • if no obvious cause, consider change in
    underlying insulin sensitivity (e.g. age, renal
    impairment).

46
Hypoglycaemia
  • Hypoglycaemia unawareness
  • Associated with human insulins (but can occur
    with any).
  • To restore warning signs adjust insulin and food
    intake to stop glucose levels dropping to lt4
    mmol/l.
  • Consider undetected night-time hypoglycaemia
    (HbAlc lt expected from blood sugar diary).
  • Driving is not permitted when hypoglycaemic
    awareness has been lost.
Write a Comment
User Comments (0)
About PowerShow.com